Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...

Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...

Fungal infections are getting harder to treat as they grow more resistant to available drugs, according to research published ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Vietnam Invasive Fungal Infection Market Key Takeaways: The Vietnam Invasive Fungal Infection (IFI) market is experiencing significant growth propelled by factors such as an increasing incidence of ...

Certain medications can affect your body's ability to tolerate hot weather. Diuretics, beta-blockers, and some antipsychotics ...

Brexafemme is the first antifungal in what is only the fourth antifungal class to reach the market, and has data showing activity in three of four MDR infections on the World Health Organization ...

F2G’s attempt to end a two-decade drought in novel therapies for invasive fungal infections has hit a hurdle after the FDA said it was unable to approve its olorofim candidate. The US regulator ...

By his side during the company’s most formative years was his son, Sir Raj Mohan, now the Executive Chairman of Unichem Group. A quiet force with a rare blend of vision and restraint, Sir Raj, amidst ...

In an emotional and inspiring cinematic debut, Unichem Group, in partnership with LUEX Healthcare UK, has premiered a legacy ...

While experts may not universally agree that hair growth shampoos can halt hair loss, they can assist in maintaining the best ...

Enzymes catalyze chemical reactions in organisms—without which life would not be possible. Leveraging AlphaFold2 artificial ...